Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cryolife Preparing For FDA Reinspection, Files Corrective Action Plan

This article was originally published in The Gray Sheet

Executive Summary

Cryolife says it expects to be ready for an FDA reinspection of its Kennesaw, Georgia facility by early December. On Oct. 8, the company submitted a corrective action plan outlining proposed steps to validate its tissue processing procedures

You may also be interested in...



FDA Reasserts Dura Mater Device Status During Interim Preceding GTPs

FDA is moving forward with rules establishing human dura mater as a Class II medical device before the agency issues guidelines transitioning the product into the purview of tissue regulation

Tissue Donor Suitability Criteria To Precede GTPs Under Revised FDA Plan

FDA will revise its plans for new risk-based tissue rulemaking by implementing donor suitability and good tissue practice (GTP) final rules concurrently, the agency says. However, the donor suitability final rule will be published first

Tissue Donor Suitability Criteria To Precede GTPs Under Revised FDA Plan

FDA will revise its plans for new risk-based tissue rulemaking by implementing donor suitability and good tissue practice (GTP) final rules concurrently, the agency says. However, the donor suitability final rule will be published first

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel